Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Panax Ginseng | Sabroxy (Oroxylum indicum) | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 200-400 mg/day of standardized extract (4-7% ginsenosides, typically G115 brand) or 1-2 g/day of dried root | — |
| Timing | Morning on an empty stomach or with food. Avoid evening dosing due to mild stimulatory effects. Acute cognitive effects noted within 1-4 hours of dosing. | — |
| Cycle Duration | Traditionally cycled 2-3 weeks on, 1-2 weeks off. Long-term continuous use exceeding 3 months is debated. | — |
| Evidence Level | moderate_human | Emerging |
Ginsenosides (primarily Rg1, Rb1, Re) are amphipathic steroidal saponins that modulate multiple neurotransmitter systems: enhancement of cholinergic transmission via increased acetylcholine synthesis and release; activation of PI3K/Akt and CREB/BDNF signaling pathways to promote neurogenesis and synaptic plasticity; attenuation of neuroinflammation through Keap1/Nrf2 signaling and suppression of the NF-kB/NLRP3 inflammasome axis; and regulation of the HPA axis to buffer cortisol response to stress. Protopanaxadiol and protopanaxatriol ginsenosides have opposing modulatory effects on GABA-A receptors.
200-400 mg/day of standardized extract (4-7% ginsenosides, typically G115 brand) or 1-2 g/day of dried root
Morning on an empty stomach or with food. Avoid evening dosing due to mild stimulatory effects. Acute cognitive effects noted within 1-4 hours of dosing.
Traditionally cycled 2-3 weeks on, 1-2 weeks off. Long-term continuous use exceeding 3 months is debated.
Contains oroxylin A — a flavonoid that inhibits PDE (phosphodiesterase), increases BDNF, and modulates dopamine signaling. Enhances focus and motivation without stimulant side effects. Also acts as a mild MAO-B inhibitor, preserving dopamine levels.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →